IUD expulsion solved with implant technology

Contraception
H Van KetsF Martinez

Abstract

In an attempt to minimize the problem of IUD expulsion, implantation technology has been developed and tested. The trials have extended from 1985 until the present time for interval as well as for immediate postabortal and post-placental insertion and fixation of the CuFix IUD (Gyne-Fix). The present article reports on an ongoing study with GyneFix interval insertion, with an improved inserter, in 820 women, observed up to 3 years, of whom 213 (25.9%) are nulligravid/nulliparous. The cumulative expulsion rate is 0.6 per 100 women-years at 3 years and is not significantly higher in the nulligravid/nulliparous group. The cumulative pregnancy rate is 0.6 and the cumulative removal rate for medical reasons 3.2 at 3 years. The total experience in this multicenter study covers approximately 14,000 woman-months. It is concluded that the design characteristics of the GyneFix (fixed, frameless, and flexible) explain the low expulsion, high efficacy and high acceptability rates. The implantation technology is very effective and the improved inserter allows easy insertion and optimal anchoring.

References

Nov 1, 1992·Contraception·D WildemeerschG Martens
Oct 1, 1992·Contraception·I Batar
Sep 1, 1988·Advances in Contraception : the Official Journal of the Society for the Advancement of Contraception·D WildemeerschW Delbarge
Jun 1, 1985·Advances in Contraception : the Official Journal of the Society for the Advancement of Contraception·M Thiery

❮ Previous
Next ❯

Citations

Apr 30, 2013·Colloids and Surfaces. B, Biointerfaces·Kuan TianXianping Xia
Aug 16, 2000·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·X CaoD Wildemeersch
Nov 22, 2002·Contraception·Francisca MartinezUNKNOWN Group for the study and follw up of Gyne in Spain
May 26, 1999·Contraception·D ReinprayoonS Suwajanakon
Jun 17, 1997·Annals of the New York Academy of Sciences·D WildemeerschM Thiery
Jun 1, 1995·Advances in Contraception : the Official Journal of the Society for the Advancement of Contraception·H van KetsF Martinez
Nov 14, 2002·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·I BonachoS Pita
Jan 1, 1997·Journal of Obstetric, Gynecologic, and Neonatal Nursing : JOGNN·E Reifsnider
May 3, 2007·Obstetrics and Gynecology Clinics of North America·David Turok
Mar 1, 1997·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·H Van KetsE Pizarro
Jun 3, 2000·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·I BatárD Wildemeersch
May 9, 2007·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·István Batár
Sep 23, 2008·Expert Review of Medical Devices·Giuseppe BenagianoManuela Farris
Aug 17, 2010·Taiwanese Journal of Obstetrics & Gynecology·Fu-Shaing PengYu-Shih Yang
Apr 12, 2003·The Journal of Family Planning and Reproductive Health Care·Rachel E D'SouzaJohn Guillebaud

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.